Physician profile
Philip John Hoffman
NPI 1942648225
$2,610.51
in general payments reported to CMS, 2019-2025
11 companies · $1,071 in 2025
The $1,071 reported for 2025 was more than what 94% of Sports Medicine (Internal Medicine) providers received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.33 · 2024: $1,442 · 2025: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415 · Travel and Lodging: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.73 |
| Travel and Lodging | $1,098.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,239.21 | 2024 | Iovera |
| Boston Scientific Corporation | $350.31 | 2025 | Intracept |
| Biotronik Nro, INC. | $280.88 | 2025 | Prospera |
| Abbott Laboratories | $144.66 | 2025 | Proclaim |
| Spr Therapeutics, INC | $129.85 | 2024 | Sprint Pns System |
| Zimmer Biomet Holdings, INC. | $115.56 | 2024-2025 | Gps III Platelet Concentration System, Biocue, Visco-3 Sodium Hyaluronate |
| Allergan, INC. | $97.33 | 2019 | |
| Hydrocision, INC. | $82.57 | 2025 | Tenjet |
| Medtronic, INC. | $81.45 | 2024-2025 | Intellis Adaptivestim |
| Mml US, INC. | $46.64 | 2025 | Reactiv8 |
| Trice Medical, INC. | $42.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.